Topical 1,25-dihydroxyvitamin D3 subverts the priming ability of draining lymph node dendritic cells

Immunology

Volumn 131, Issue 3, 2010, Pages 415-425

  Gorman, Shelley ^a   Judge, Melinda A ^a   Hart, Prue H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Contact hypersensitivity; Dendritic cells; Skin; Tolerance; Vitamin D

Indexed keywords

CALCITRIOL; CD86 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; DENDRITIC CELL; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADMINISTRATION, TOPICAL; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; CALCITRIOL; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DERMATITIS, CONTACT; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOSUPPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 78649411499     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03315.x     Document Type: Article

References (34)

1. 3 (calcitriol) in human skin by microdialysis. Arch Dermtaol Res 2003; 295:24-8.
2. 3 is associated with an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol 2007; 127:707-15.
3. 3 on purified mouse Langerhans cells. Cell Immunol 2007; 245:70-9.
4. 3. J Leukoc Biol 2007; 81:250-62.
5. 3 enhances degranulation of mast cells. Mol Cell Endocrinol 1998; 142:49-55.
6. + cells in the draining lymph nodes. J Immunol 2007; 179:6273-83.
7. Ghoreishi M, Bach P, Obst J, Komba M, Fleet JC, Dutz JP. Expansion of antigen-specific regulatory T cells with the topical vitamin D analog calcipotriol. J Immunol 2009; 182:6071-8.
8. 3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007; 8:285-93.
9. Sigmon JR, Yentzer BA, Feldman SR. Calcitriol ointment: a review of a topical vitamin D analog for psoriasis. J Dermatolog Treat 2009; 20:208-12.
10. Gorman S, Judge MA, Hart PH. Immune-modifying properties of topical vitamin D: focus on dendritic cells and T cells. J Steroid Biochem Mol Biol 2010; Mar 6 (Epub)
11. 3 on Langerhans cells and contact hypersensitivity in mice. Arch Dermatol Res 1992; 284:368-70.
12. Damian DL, Kim YJ, Dixon KM, Halliday GM, Javeri A, Mason RS. Topical calcitriol protects from UV-induced genetic damage but suppresses cutaneous immunity in humans. Exp Dermatol 2009; Sept 16 (Epub).
13. Hanneman KK, Scull HM, Cooper KD, Baron ED. Effect of topical vitamin D analogue on in vivo contact sensitisation. Arch Dermatol 2006; 142:1332-4.
14. 3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-β. J Immunol 2008; 180:5211-21.
15. 3 plays an important role in the diversification of adaptive immune responses. J Immunol 2009; 182:4296-305.
16. Von Garnier C, Wikstrom ME, Zosky G et al. Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa. J Immunol 2007; 179:5748-59.
17. Hart PH, Grimbaldeston MA, Swift GJ, Jaksic A, Noonan FP, Finlay-Jones JJ. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 1998; 187:2045-53.
18. + T cells in lymph nodes of UVB-irradiated mice suppress immune responses to new antigens both in vitro and in vivo. J Invest Dermatol 2007; 127:915-24.
19. Wilson NS, El-Sukkari D, Belz GT, Smith CM, Steptoe RJ, Heath WR, Shortman K, Villadangos JA. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003; 102:2187-94.
20. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Immunol 2008; 8:935-47.
21. Alder HS, Steinbrink K. Tolerogenic dendritic cells in health and disease: friend and foe. Eur J Dematol 2007; 17:476-91.
22. 3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol 2009; 182:2074-83.
23. 3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167:1945-53.
24. 3 deficiency enhances contact hypersensitivity in male but not female mice. Cell Immunol 2009; 255:33-40.
25. + regulatory T cells. J Immunol 2008; 181:6923-33.
26. 3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007; 178:145-53.
27. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009; 132:1146-60.
28. Griffin MD, Dong X, Kumar R. Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation. Arch Biochem Biophys 2007; 460:218-26.
29. 3-modified regulatory dendritic cells. Clin Exp Immunol 2009; 157:48-59.
30. Loser K, Mehling A, Loeser S et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006; 12:1372-9.
31. + T cells to enhance the development of Th2 cells. J Immunol 2001; 167:4974-80.
32. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003; 89:922-32.
33. + T cells. J Immunol 2002; 168:1181-9.
34. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324:23-33.